Literature DB >> 28917519

Endoscopic or arthroscopic iliopsoas tenotomy for iliopsoas impingement following total hip replacement. A prospective multicenter 64-case series.

W Guicherd1, N Bonin2, T Gicquel3, J E Gedouin4, X Flecher5, M Wettstein6, M Thaunat7, N Prevost8, E Ollier9, O May10.   

Abstract

INTRODUCTION: Impingement between the acetabular component and the iliopsoas tendon is a cause of anterior pain after total hip replacement (THR). Treatment can be non-operative, endoscopic or arthroscopic, or by open revision of the acetabular component. Few studies have assessed these options. The present study hypothesis was that endo/arthroscopic treatment provides rapid pain relief with a low rate of complications.
METHODS: A prospective multicenter study included 64 endoscopic or arthroscopic tenotomies for impingement between the acetabular component and the iliopsoas tendon, performed in 8 centers. Mean follow-up was 8months, with a minimum of 6months and no loss to follow-up. Oxford score, patient satisfaction, anterior pain and iliopsoas strength were assessed at last follow-up. Complications and revision procedures were collated. Forty-four percent of patients underwent rehabilitation.
RESULTS: At last follow-up, 92% of patients reported pain alleviation. Oxford score, muscle strength and pain in hip flexion showed significant improvement. The complications rate was 3.2%, with complete resolution. Mean hospital stay was 0.8 nights. In 2 cases, arthroscopy revealed metallosis, indicating revision of the acetabular component. The only predictive factor was acetabular projection on oblique view. Rehabilitation significantly improved muscle strength.
CONCLUSION: Endoscopic or arthroscopic tenotomy for impingement between the acetabular component and the iliopsoas tendon following THR significantly alleviated anterior pain in more than 92% of cases. The low complications rate makes this the treatment of choice in case of failure of non-operative management. Arthroscopy also reorients diagnosis in case of associated joint pathology. Projection of the acetabular component on preoperative oblique view is the most predictive criterion, guiding treatment.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Arthroscopic tenotomy; Iliopsoas impingement; Iliopsoas tendon; Total hip replacement

Mesh:

Year:  2017        PMID: 28917519     DOI: 10.1016/j.otsr.2017.09.007

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  5 in total

1.  Iliopsoas impingement after total hip arthroplasty: Does the CT-scan have any role? Our Algorithm proposal.

Authors:  Carla Carbonell-Rosell; Diego Soza; Oriol Pujol; Matias de Albert de Delás-Vigo; Alba Antón; Victor Barro
Journal:  J Orthop       Date:  2022-08-27

2.  Arthroscopic treatment of iliopsoas impingement syndrome after hip arthroplasty.

Authors:  Paolo Di Benedetto; Giuseppe Niccoli; Stefano Magnanelli; Alessandro Beltrame; Renato Gisonni; Vanni Cainero; Araldo Causero
Journal:  Acta Biomed       Date:  2019-01-10

3.  A Case of Iliopsoas Bursitis With Compressive Femoral Nerve Palsy Treated With Iliopsoas Tendon Release.

Authors:  Jordan Conroy; Sandi Caus; Nathaniel J Nelms
Journal:  Arthroplast Today       Date:  2022-03-18

4.  Metal Artefact Reduction Sequences (MARS) in Magnetic Resonance Imaging (MRI) after Total Hip Arthroplasty (THA) : A non-invasive approach for preoperative differentiation between periprosthetic joint infection (PJI) and aseptic complications?

Authors:  André Busch; Marcus Jäger; Sascha Beck; Alexander Wegner; Erik Portegys; Dennis Wassenaar; Jens Theysohn; Johannes Haubold
Journal:  BMC Musculoskelet Disord       Date:  2022-06-28       Impact factor: 2.562

5.  Results after arthroscopic treatment of iliopsoas impingement after total hip arthroplasty.

Authors:  A Zimmerer; M Hauschild; R Nietschke; M M Schneider; G Wassilew; C Sobau; W Miehlke
Journal:  Arch Orthop Trauma Surg       Date:  2020-10-12       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.